In last trading session, Viking Therapeutics Inc (NASDAQ:VKTX) saw 5.36 million shares changing hands with its beta currently measuring 0.63. Company’s recent per share price
Viking Therapeutics Inc (NASDAQ:VKTX) has a beta value of 0.65 and has seen 1.08 million shares traded in the recent trading session. The company, currently
In the latest trading session,, 1.17 million Viking Therapeutics Inc (NASDAQ:VKTX) shares changed hands as the company’s beta touched 0.64. With the company’s most recent
During the recent session, Viking Therapeutics Inc (NASDAQ:VKTX)’s traded shares were 0.67 million, with the beta value of the company hitting 0.66. At the last
Viking Therapeutics Inc (NASDAQ:VKTX)’s traded shares stood at 2.52 million during the last session, with the company’s beta value hitting 0.66. At the close of
In the latest trading session,, 0.68 million Viking Therapeutics Inc (NASDAQ:VKTX) shares changed hands as the company’s beta touched 0.65. With the company’s most recent
Viking Therapeutics Inc (NASDAQ:VKTX) has a beta value of 0.67 and has seen 2.75 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne